MLN8054 Uses, Dosage, Side Effects and more

MLN8054 has been used in trials studying the treatment of Colon Neoplasm, Breast Neoplasm, Bladder Neoplasm, Pancreatic Neoplasm, and Advanced Malignancies.

Trade Name MLN8054
Generic MLN8054
Type
Formula C25H15ClF2N4O2
Weight Average: 476.862
Monoisotopic: 476.085159861
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

How MLN8054 works

MLN8054 is a selective small-molecule Aurora A kinase inhibitor that has entered Phase I clinical trials for advanced solid tumors. MLN8054 inhibits recombinant Aurora A kinase activity in vitro and is selective for Aurora A over the family member Aurora B in cultured cells. MLN8054 treatment results in G2/M accumulation and spindle defects and inhibits proliferation in multiple cultured human tumor cells lines.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share